S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
NYSE:RMED

Ra Medical Systems - RMED Stock Forecast, Price & News

$4.97
+0.43 (+9.47%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$4.36
$6.30
50-Day Range
$2.11
$6.78
52-Week Range
$2.03
$100.50
Volume
4.01 million shs
Average Volume
618,568 shs
Market Capitalization
$5.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
RMED stock logo

About Ra Medical Systems (NYSE:RMED) Stock

Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.

Receive RMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ra Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

RMED Stock News Headlines

Can Pfizer, Johnson & Johnson Continue Outperforming the Index? (RMED)
Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months.
Why Was Ra Medical Systems (RMED) Stock Up 20% Today?
5 Penny Stocks to Sell Before They Hit Zero
Why Is Ra Medical Systems (RMED) Stock Up 30% Today?
Ra Medical Systems Receives NYSE American Notice
See More Headlines
Receive RMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ra Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

RMED Company Calendar

Last Earnings
11/14/2022
Today
12/09/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
58
Year Founded
N/A

Profitability

Net Income
$-25,070,000.00
Net Margins
-110,533.34%
Pretax Margin
-142,047.39%

Debt

Sales & Book Value

Annual Sales
$20,000.00
Book Value
$97.53 per share

Miscellaneous

Free Float
1,085,000
Market Cap
$5.42 million
Optionable
Not Optionable
Beta
0.81

Key Executives

  • Mr. Jonathan Will McGuireMr. Jonathan Will McGuire (Age 59)
    CEO & Director
    Comp: $911.12k
  • Mr. Brian D. Conn
    Interim CFO, Principal Financial Officer & Principal Accounting Officer
  • Ms. Tiah Reppas
    VP, Chief Accounting Officer & Corp. Controller
  • Ms. Maria Villanueva
    VP & Compliance Officer
  • Mr. Al Memmolo B.S. MBA
    Sr. VP of Clinical, Quality & Regulatory Affairs













RMED Stock - Frequently Asked Questions

Should I buy or sell Ra Medical Systems stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ra Medical Systems in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RMED shares.
View RMED analyst ratings
or view top-rated stocks.

How have RMED shares performed in 2022?

Ra Medical Systems' stock was trading at $78.00 on January 1st, 2022. Since then, RMED stock has decreased by 93.6% and is now trading at $4.97.
View the best growth stocks for 2022 here
.

How were Ra Medical Systems' earnings last quarter?

Ra Medical Systems, Inc. (NYSE:RMED) posted its quarterly earnings data on Monday, November, 14th. The company reported ($3.86) EPS for the quarter. Ra Medical Systems had a negative trailing twelve-month return on equity of 169.55% and a negative net margin of 110,533.34%.

When did Ra Medical Systems' stock split?

Ra Medical Systems's stock reverse split before market open on Monday, October 3rd 2022. The 1-50 reverse split was announced on Monday, October 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of Ra Medical Systems own?
When did Ra Medical Systems IPO?

(RMED) raised $50 million in an initial public offering (IPO) on Thursday, September 27th 2018. The company issued 3,300,000 shares at $14.00-$16.00 per share. Piper Jaffray and Cantor served as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers.

What is Ra Medical Systems' stock symbol?

Ra Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMED."

Who are Ra Medical Systems' major shareholders?

Ra Medical Systems' stock is owned by many different retail and institutional investors. Top institutional investors include Spire Wealth Management (95.25%), WealthTrust Axiom LLC (30.28%) and Vanguard Group Inc. (20.37%). Insiders that own company stock include Andrew C Jackson, Dean Irwin, Jonathan Will Mcguire, Martin Burstein, Martin J Colombatto, Richard Mejia Jr and William R Enquist.
View institutional ownership trends
.

How do I buy shares of Ra Medical Systems?

Shares of RMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ra Medical Systems' stock price today?

One share of RMED stock can currently be purchased for approximately $4.97.

How much money does Ra Medical Systems make?

Ra Medical Systems (NYSE:RMED) has a market capitalization of $5.42 million and generates $20,000.00 in revenue each year. The company earns $-25,070,000.00 in net income (profit) each year or ($92.36) on an earnings per share basis.

How can I contact Ra Medical Systems?

Ra Medical Systems' mailing address is 2070 Las Palmas Drive, Carlsbad CA, 92011. The official website for the company is www.ramed.com. The company can be reached via phone at (760) 804-1648 or via email at jcain@lhai.com.

This page (NYSE:RMED) was last updated on 12/9/2022 by MarketBeat.com Staff